News | September 09, 2025
Alcon India launches Unity VCS/CS for vitreoretinal and cataract surgery
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
The approved ANDA is therapeutically equivalent to the reference listed drug product
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million in the U.S.
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
The company has received five final approvals
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
Subscribe To Our Newsletter & Stay Updated
